Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed about submission of the Press Release on ‘SPARC Announces research collaboration with HitGen, a Chinese company, to identify and discover novel small molecule leads for SPARC’, being released by the Company, which is self-explanatory.
The above information is a part of company’s filings submitted to BSE.